Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations
| Brand name | PANTOPRAZOLE SODIUM |
| Generic name | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Distributed by / for | Baxter Healthcare Corporation |
| NDC | 0338-9648-12 |
| Full product label | Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12. |
| Recalling firm | Baxter Healthcare Corporation |
| Distribution | US Nationwide; Puerto Rico; and Chile. |
| Quantity | N/A |
| Recall initiated | 2026-08-06 |
| Report date | 2026-09-09 |
| Recall completed | — |
| Recall number | D-0812-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Deerfield IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗